Food, drugs, devices › Central Admixture Pharmacy Services Inc

Drug recall: Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag,

FDA enforcement event 99535 · Class III · initiated 16 Jul 2026 · status Ongoing

DrugVoluntary: Firm initiated1 product recordNorcross, GA

Central Admixture Pharmacy Services Inc (Norcross, GA) initiated this drug recall on 16 Jul 2026; FDA lists 1 product record under event 99535, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 15% of the 234 drug enforcement events initiated in 2026 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Central Admixture Pharmacy Services Inc has 10 enforcement events on this register, with a median of 32 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Central Admixture Pharmacy Services Inc, Norcross, GA.

Reason for recall

"Incorrect Product Formulation"

Distribution

"GA only"

Product records

Recall number	Product	Quantity	Class	Status	Report date
D-0740-2026	Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Inc., Atlanta, 1750 Corp Dr. Ste 725, Norcross, GA 30093 (844) 903-6418	(2) patient-specific TPN prescriptions	Class III	Ongoing	12 Aug 2026

Context

15%of 2026 drug events are Class III234 events that year

1product record in this eventfirm median: 32

10events on this register for the firm

Other enforcement events for Central Admixture Pharmacy Services Inc

Initiated	Product (first record)	Type	Class	Records
2 Jun 2026	Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856-0-1Compound Volume	Drug	Class II	1
20 Feb 2025	PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy Servi	Drug	Class I	1
21 Sep 2023	fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services,	Drug	Class II	32
17 Aug 2023	CARDIOPLEGIA SOLUTION, 20 mEq K, Maintenance 4:1, Low Potassium, Total Volume = 810 mL, EVA Bag, Rx only, Central Admixt	Drug	Class II	32
17 Jul 2023	fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc.,	Drug	Class II	39
14 Jul 2023	rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix	Drug	Class II	95
28 Apr 2023	Microplegia (MSA/MSG 0.92 Molar) packaged in 125 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh	Drug	Class II	108
17 Dec 2014	University of Alabama Birmingham TPN Neonatal Starter Bag, compound vol: 100 ml, Trophamine 4% Dextrose 10%, sterile inj	Drug	Class I	34
28 May 2014	PEDIATRIC CARDIOPLEGIA, 255 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150	Drug	Class I	4

All 10 events for Central Admixture Pharmacy Services Inc

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Incorrect Product Formulation"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "GA only"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.